Attached files
| file | filename |
|---|---|
| 10-K - 10-K - NORTHWEST BIOTHERAPEUTICS INC | tv491101_10k.htm |
| EX-21.1 - EXHIBIT 21.1 - NORTHWEST BIOTHERAPEUTICS INC | tv491101_ex21-1.htm |
| EX-10.69 - EXHIBIT 10.69 - NORTHWEST BIOTHERAPEUTICS INC | tv491101_ex10-69.htm |
| EX-31.1 - EXHIBIT 31.1 - NORTHWEST BIOTHERAPEUTICS INC | tv491101_ex31-1.htm |
| EX-32.1 - EXHIBIT 32.1 - NORTHWEST BIOTHERAPEUTICS INC | tv491101_ex32-1.htm |
EXHIBIT 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the incorporation by reference in the Registration Statement of Northwest Biotherapeutics, Inc. on Form S-3 [File No. 333-213777] of our report dated April 17, 2018, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of Northwest Biotherapeutics, Inc. and Subsidiaries as of December 31, 2017 and 2016 and for each of the two years in the period ended December 31, 2017, which report is included in this Annual Report on Form 10-K of Northwest Biotherapeutics, Inc. for the year ended December 31, 2017.
/s/ Marcum llp
Marcum llp
New York, NY
April 17, 2018